Top

Cancer Chemotherapy and Pharmacology

Published in:

01-07-2000

Exploitation of the B cell repertoire for the identification of human tumor antigens

Author: Michael Pfreundschuh

Published in: Cancer Chemotherapy and Pharmacology | Special Issue 1/2000

Title: Exploitation of the B cell repertoire for the identification of human tumor antigens
Author: Michael Pfreundschuh
Publication date: 01-07-2000
Publisher: Springer-Verlag
Published in: Cancer Chemotherapy and Pharmacology / Issue Special Issue 1/2000
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI: https://doi.org/10.1007/PL00014046

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Special Issue 1/2000

Melanoma vaccines: the paradox of T cell activation without clinical response

Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies

Development of a cancer vaccine: peptides, proteins, and DNA

Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer

Preface

Keynote webinar | Spotlight on antibody–drug conjugates in cancer